tirzepatide coming off shortage list The recent announcement that has been removed from the FDA's drug is good news for people looking for effective weight loss solutions. But, it could mean the compounded versions Tirzepatide OFF FDA shortage list.

This is the first randomized controlled trial of [tirzepatide] and [ixekizumab] in patients with PsA and overweight or obesity that addresses the comprehensive management needs of this patient population, with a positive meaningful impact in multiple domains of PsA disease, including disease control and its comorbidities, Merola and colleagues wrote

Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats

Request a baseline DXA scan if you are a postmenopausal woman or have risk factors for osteoporosis

doi: 10.1093/jsxmed/qdae001.148

Genetic personalization ensures your medication schedule respects your physiology rather than following a one-size-fits-all frequency pattern

This practical approach helps patients sustain treatment without lifestyle disruption